Discovery of novel MDM2 inhibitor with antitumor activity in p53 wild-type cancer models March 14, 2022
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent Nav1.8 channel blockers March 14, 2022
New Bruton tyrosine kinase inhibitors identified at Beijing Innocare Medical Technology March 14, 2022
TYK2 inhibitors described by Ennovabio (Zhejiang) Pharmaceuticals, Shanghai Ennova Biopharmaceutical March 14, 2022
RSS